Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effects of Mesalamine and Amitriptyline in IBS: a Randomized Clinical Trial

NCT02190526 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.

NCT NCT02190526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02190526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effects of Mesalamine and Amitriptyline in IBS: a Randomized Clinical Trial
Lead sponsor
Tehran University of Medical Sciences
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2014
Completion date
December 31, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea- predominant irritable bowel syndrome, quality of life